1. Home >
  2. WuXi Biologics Acquires CMAB Biopharma

M&A Deal Summary

WuXi Biologics Acquires CMAB Biopharma

On May 7, 2021, WuXi Biologics acquired life science company CMAB Biopharma

Acquisition Highlights
  • This is WuXi Biologics’ 3rd transaction in the Life Science sector.
  • This is WuXi Biologics’ 3rd transaction in China.

M&A Deal Summary
Date 2021-05-07
Target CMAB Biopharma
Sector Life Science
Buyer(s) WuXi Biologics
Deal Type Add-on Acquisition

Target

CMAB Biopharma

Suzhou, China
CMAB Biopharma is a full-service contract development and manufacturing organization (CDMO) dedicated to providing process development and manufacturing services for biologic products. The company provides bespoke development manufacturing services of antibodies and biologics for clients in China and across the globe. Its adaptable, service-oriented business enables clients to take their innovative concepts for tomorrow’s medicines from DNA to clinical products today. CMAB Biopharma was formed in 2017 and is based in Suzhou, China.

Search 204,883 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

WuXi Biologics

Wuxi, China
Category Company
Founded 2014
Sector Life Science
Employees12,435
Revenue 17.0B CNY (2023)
DESCRIPTION

WuXi Biologics is an open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. WuXi Biologics was founded in 2014 and is based in Wuxi, China.

DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 1 of 1
Country (China) 3 of 3
Year (2021) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-07 Bayer Wuppertal

Wuppertal, China

Bayer Wuppertal produces around 20 active ingredients for the world market in the plant and the processes are sustainably developed. Bayer Wuppertal site consists of four parts of the plant: the plant on the Wupper, the research and development center, and the works sewage treatment plant as well as a branch in Cologne.

Buy -
Mergr

Product

Company

Legal